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Megalocytivirus is causing economically serious mass mortality by infecting fish in and around the Pacific
region of Asia. The recent emergence of many new iridoviruses has drawn attention to the marked taxonomic
variation within this virus family. Most studies of these viruses have not included extensive study of these
emergent species. We explored the emergence of red sea bream iridovirus (RSIV) on a fish farm in Japan, and
we specifically endeavored to quantify genetic and phenotypic differences between RSIV isolates using in vitro
and in vivo methods. The three isolates had identical major capsid protein sequences, and they were closely
related to Korean RSIV isolates. In vitro studies revealed that the isolates differed in replication rate, which
was determined by real-time quantitative PCR of viral genomes in infected cells and cell culture supernatant,
and in cell viability, estimated by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide)
assay for infected cells. In vivo studies showed that the isolates exhibit different virulence characteristics:
infected red sea bream showed either acute death or subacute death according to infection with different
isolates. Significant differences were seen in the antigenicity of isolates by a formalin-inactivated vaccine test.
These results revealed that variant characteristics exist in the same phylogenetic location in emergent iridovi-
ruses. We suggest that this strain variation would expand the host range in iridoviral epidemics.
Iridoviruses are designated as icosahedral cytoplasmic DNA
viruses; this group of viruses has different hosts, including fish,
amphibians, and insects, causing economic and environmental
problems. The family Iridoviridae includes five genera: Iridovi-
rus, Chloriridovirus, Ranavirus, Lymphocystivirus, and Megalo-
cytivirus (45). Piscine iridoviruses belong to the genera Rana-
virus, Lymphocystivirus, and Megalocytivirus. In recent years,
the genotypical variation between newly found iridovirus
strains included in the genus Ranavirus has been studied in this
viral family (5). However, the properties of and variation be-
tween iridovirus species have not been well characterized ex-
cept for a few iridoviruses isolated from amphibians (11, 46),
fish (8, 18, 19), and insects (23, 42, 44). Most studies attempting
to differentiate variants have relied on genotypic rather than
phenotypic properties.
Members of the Megalocytivirus genus produce characteristic
basophilic inclusion bodies in the enlarged cells of host fish
organs, which have been collected from mass mortalities oc-
curring in wild and cultured fish species (14, 37). Red sea
bream (Pagrus major) aquaculture has suffered great losses
from the prevalence of red sea bream iridovirus (RSIV) infec-
tion in Japan. RSIV has been assigned to the Megalocytivirus
genus. The virus was first isolated from cultured red sea bream
in western Japan in 1990 (22).
Many other piscine iridoviruses have been reported in Asian
countries (7, 24, 25) from more than 100 different species (41),
including freshwater and marine fish (19). RSIV is closely
related genetically to viruses isolated from ornamental fish in
Southeast Asia, based on nucleotide sequence studies (21, 39).
A formalin-inactivated RSIV vaccine has been used in juvenile
marine fish against this disease (31, 32).
The incidence of iridovirus infection has been increasing
among cultured fish in Japan (29, 30). In addition, genetic and
phenotypic iridovirus variants suggest the presence of diverse
variants in this virus group (16). In the present study, we
examined the detailed properties of three RSIV isolates from
two fish species collected from fish farms in western Japan.
Using in vitro and in vivo processes, we focused close exami-
nation specifically on quantitative genetic and phenotypic dif-
ferences between the three isolates. The aim of this study was
to increase understanding of the epidemiology of RSIV.
MATERIALS AND METHODS
Viruses and cells. Viral isolates from three individual fish specimens (farm
cultured) were used in this study. The first isolate (strain U-1) was isolated from
an RSIV-infected red sea bream from Uranouchi Bay, Kochi, Japan, in 2001
(20). The second isolate (strain KST-Y-1) was isolated from an RSIV-infected
yellow tail in Mitoyo, Kagawa, Japan, in 2004. The third isolate (strain U-6) was
isolated from an RSIV-infected red sea bream from Uranouchi Bay, Kochi,
Japan, in 2005. The isolates were inoculated at a multiplicity of infection of 1.0
onto confluent monolayers of cloned red sea bream fin (CRF-1) cells in 25-cm2
tissue culture flasks containing 25 ml of Eagle’s minimum essential medium with
Hanks’ balanced salt solution supplemented with 10% fetal bovine serum, 100 U
penicillin/ml, 100 g/ml streptomycin, and 200 g/ml neomycin and incubated at
24°C for 5 days or up to the time point at which maximum cytopathic effect was
observed (21).
PCR and DNA sequencing. Each viral isolate was inoculated onto confluent
monolayers of CRF-1 cells in three replicate 25-cm2 flasks as described above.
DNA extraction from these iridovirus isolates was performed by a proteinase K
lysis method (30). Briefly, the infected cell culture including supernatant was
centrifuged at 50  g for 20 min at 4°C. Then, the precipitate containing free
virus particles and cell-associated nucleocapsids was digested with 100 U/ml
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proteinase K at 55°C for 2 h and subjected to phenol-chloroform DNA extrac-
tion. The concentrations and purity of the extracted DNA were determined
spectrophotometrically.
A specific primer set for major capsid protein (MCP) genes of RSIV was
designed from the RSIV ehime-1 strain sequence (GenBank accession number
AB080362) and rock sea bream iridovirus (RBIV) sequence (GenBank accession
number AY532609) (9). This region was amplified with Ex Taq polymerase
(Takara Bio Inc.). The thermal cycling conditions consisted of 35 cycles of
denaturation for 1 min at 94°C, annealing for 1 min at 54°C, and extension at
72°C, followed by a final extension at 72°C for 5 min. The PCR products were
purified with a commercial kit (Easytrap, version 2; Takara Bio Inc.) and cloned
into a plasmid vector for subsequent transformation of Escherichia coli with a
commercial kit (pGEM-T Easy Vector System; Promega Corp.). Plasmid DNA
was purified from E. coli cells with a commercial kit (QIAprep Miniprep System;
Qiagen, Inc.) for sequence analysis using the automated DNA sequencer ABI
Prism 3100-Avant Genetic Analyzer (Applied Biosystems).
Phylogenetic analysis. The DNA sequences were compared with the
GenBank/EMBL databases using BLAST (National Center for Biotechnology In-
formation). Sequences were aligned using Clustal W (40), and then a phyloge-
netic tree was made with the TreeView program (33). The phylogenetic rela-
tionships between species were determined using the neighbor-joining method
(36), and the reliability of the neighbor-joining tree was inferred using the
bootstrap method (12) with 1,000 replicates.
PCR-RFLP analysis. In order to detect genetic differences in the three RSIV
isolates, restriction fragment length polymorphism (RFLP) analysis was em-
ployed. Each viral isolate was inoculated onto confluent monolayers of CRF-1
cells in three replicates of 25-cm2 flasks as described above. The flasks were
frozen and thawed three times. The infected cell cultures including supernatant
were centrifuged at 50  g for 20 min at 4°C. The supernatants containing free
viral particles and cell-associated nucleocapsids were treated with DNase at 37°C
for 30 min and then boiled at 94°C for 30 min. The solutions were digested with
proteinase K (0.2 mg/ml) at 55°C for 2 h, subjected to phenol-chloroform ex-
traction, and then precipitated with ethanol.
We designed seven primer sets for the amplification of RSIV genomic DNA
and RFLP analysis, as shown in Table 1. These regions were amplified with LA
Taq polymerase (Takara Bio Inc.) and 50 pmol of each primer. Reaction con-
ditions consisted of an initial denaturation step at 94°C for 1 min, followed by 35
cycles of denaturation (94°C for 30 s), annealing (52 to 60°C for 30 s), and
extension (72°C for 2 to 4 min) and a final extension step at 72°C for 7 min. The
products were digested with restriction enzymes HaeII, HapII, and NdeI (Takara
Bio Inc.), reacted for 6 h. Digested products were separated by 1.2% agarose gel
electrophoresis, stained with ethidium bromide, and photographed under UV
illumination.
Real-time qPCR. Oligonucleotide sequences were determined by referencing
with an orange-spotted grouper iridovirus (OSGIV) structural gene for ATPase
(GenBank accession number AY894343) (27). Primer Express software (version
1.5; PE Applied Biosystems) was used to design a TaqMan probe (5-FAM-
AAATCTATCATTGCAGCCAAGCGGC-TAMRA-3, where FAM is 6-car-
boxyfluorescein and TAMRA is 6-carboxytetramethylrhodamine) and the for-
ward (5-GCGGCAAGTCGGTGCTAA-3) and reverse (5-CGCGGCGGGA
ATTATG-3) PCR primer set, and the locations were nucleotides 98 to 115 on
the forward side, 117 to 142 on the proof side, and 144 to 159 and on the reverse
side. The primers and probe, designed to anneal and amplify a 61-bp target
sequence within the ATPase gene, were assessed for species specificity by
BLAST search to determine homology to known sequences. The quantitative
PCR (qPCR) was performed in triplicate for each sample in a 25-l reaction
mixture containing 12.5 l of 2 TaqMan Universal PCR Master Mix (Applied
Biosystems, Inc.), 2.5 l of template DNA, 900 nmol of each primer, and 250
nmol of fluorescent probe in a 96-well optical PCR plate, which was set on an
ABI Prism 7300 Sequence Detection System (Applied Biosystems, Inc.). The
real-time PCR protocol consisted of holding samples at 50°C for 2 min, followed
by denaturation at 95°C for 10 min and then 40 cycles of 95°C for 15 s and 60°C
for 1 min.
The qPCR was standardized by using a DNA sample with serial concentra-
tions. An approximately full-length fragment of the RSIV ATPase gene, con-
taining the full 61-bp target sequence, was a specific primer set for the ATPase
of this virus. We designed the forward (5-ATGGAAATCCAAGAGTTGTCC
CTG-3) and reverse (5-TTACACCACGCCAGCCTTG-3) PCR primers. This
region was amplified with Ex Taq polymerase. The thermal cycling conditions
consisted of 35 cycles of denaturation for 1 min at 94°C, annealing for 1 min at
54°C, and extension at 72°C, followed by a final extension for 5 min at 72°C. The
amplicon was cloned into a plasmid vector and purified with plasmid DNA as
described above. The DNA concentration was determined using a competitive
PCR with a commercial kit (Competitive DNA Construction Kit; Takara Bio,
Inc.). Serial dilution was used to prepare standards that ranged in concentration
from 101 to 108 copies per l. qPCR was performed on these standards, as
described above, and linear regression was used to create a standard curve for
interpolating the concentrations of unknown samples. Variability in the qPCR
was measured as the square of Pearson’s product-moment correlation coefficient
(r2) describing the relationship between the known concentrations of standards
and their concentrations inferred by qPCR.
Analysis of viral replication. Replication profiles of the three RSIV isolates
were analyzed in vitro. Confluent monolayers of CRF-1 cells in three replicate
25-cm2 tissue culture flasks containing 10 ml of medium were prepared as
described above. The cells were inoculated with 500 l of each RSIV isolate
containing 103 copies of viral DNA solution at a multiplicity of infection of 1.0,
with two uninoculated flasks to serve as controls.
Every 24 h, 0.3 ml of cell culture supernatant was removed from each flask, and
the infected cells were collected from each flask at each time point. The viral
DNA was extracted using a commercial kit (QIAamp DNA Blood Mini Kit;
Qiagen, Inc.). Virus concentration (genomes per milliliter) was determined by
real-time qPCR for each isolate at each time point.
MTT assay. An MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) assay was performed to analyze dead or live virus-infected cells. CRF-1
cell monolayers were prepared in 96-well tissue culture plates where approxi-
mately 5  104 cells per well were seeded and then cultured overnight at 24°C.
An MTT assay was performed on each monolayer after inoculation with 50 l of
a DNA solution containing 103 virus copies using a commercial kit (MTT cell
count kit; Nakalai Tesque). Briefly, the cultured monolayers were inoculated
with RSIV culture supernatant, and then every 24 h MTT was added to each well.
After incubation for 4 h at 24°C, culture medium was removed from the well, and
then formazan precipitate dissolved in dimethyl sulfoxide was added. The ab-
sorbance of the mixture was determined at 570 nm (reference, 670 nm) using
Mutiscan JX, version 1.1 (Thermo Lab Systems), in duplicate.
Electron microscopy. Virus particles in infected cultured cells were observed
by transmission electron microscopy. CRF-1 cells were infected with U-1, KST-
Y-1, or U-6 virus and then fixed at every 24 h in 2.5% glutaraldehyde overnight
at 4°C. The cells were sectioned by ultramicrotome and stained with uranyl
acetate, and then virus particles were observed using transmission electron mi-
croscopy (H-7100; Hitachi).
Experimental challenge and sampling of tissue and organs. Juvenile red sea
bream (body weight, 8.29  3.8 g) were used for virulence testing. Three sets of
50 fish each were kept in 200-liter aquaria with running seawater, which was
recirculated at a temperature of 28°C. Each set of fish was divided into four
groups and challenged intraperitoneally with a different dose of three RSIV
isolates or with phosphate-buffered saline (PBS) in control groups. First, one
group from each set was inoculated with 103 50% tissue culture infective doses
(103 TCID50)/fish of U-1, U-6, and KST-Y-1 virus. The second and third groups
from each set received 104 and 105 TCID50/fish, respectively, of the three strains.
The fourth group from each set was injected with PBS as a control. Cumulative
mortality was examined for 14 days. Tissues were collected from fish infected
with a 60% lethal dose: for U-1, 104 TCID50 /fish; for U-6, 103 TCID50/fish; and
for KST-Y-1, 104 TCID50/fish. Three to 10 days after infection, six fish were
TABLE 1. Primers used for PCR-RFLP analysis in this study
Primer set Regiona Primer sequence (5–3)
Set 1 1L-6L TGATCTTTTAATACCCCTG
GCCACCAACTATGCGTTACG
Set 2 20R-22R GCCACACTGCGCCACAGTG
TGTTTGTGCACGTACGCCAAC
Set 3 32L-35L TCAAATGCGATAGCGCTTGC
GGCTGTGTATATCAGCTACT
Set 4 45L-50R CGCGTAACAGGCGCCAGTC
GTGTCGCCCGCCCACGCGAC
Set 5 71L-73R GTGCACATGACGGCCGATGAG
CGGTGAAACACTTGAAGCC
Set 6 85R-88L ATAAAACTGATTGTGGTGCC
GACAGCGTTGGCCAGCTGCT
Set 7 111L-112R GTGTCTCTCAGTCATGATGAC
CGGGCAACAGGCAGACGCATG
a Regions were numbered according to OSGIV open reading frames
(GenBank accession number AY894343).
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randomly collected from each group, and tissue samples were harvested from the
spleen, kidney, liver, heart, brain, and suborbital musculature. Tissue samples
from three fish were stored at 80°C, and those from another three fish were
fixed in 3% formalin (Sigma, St. Louis, MO) in PBS for 24 h and stocked in the
same fresh formalin solution until pathological observation.
Virus distribution in fish organs. Tissue samples from the infected fish were
homogenized in PBS and centrifuged at 2,500  g for 10 min. The supernatant
was digested with protease K (0.2 mg/ml) at 55°C for 2 h, followed by phenol-
chloroform extraction and ethyl alcohol precipitation. The genomic DNA in the
precipitates was dissolved in a Tris-EDTA buffer and used as a template for
detecting the RSIV ATPase gene described above. The PCR products were
separated by 1.2% agarose gel electrophoresis, stained with ethidium bromide,
and photographed under UV illumination.
Pathological observation. Fixed tissue samples were dehydrated in ethanol and
embedded in paraffin. The embedded tissues were sectioned about 5 m thick,
stained with hematoxylin and eosin, and then observed under a microscope.
Preparation of vaccine. A formalin-inactivated RSIV vaccine was prepared as
described previously (32). Briefly, CRF-1 cells infected with the three strains,
U-1, U-6, and KST-Y-1, were collected and centrifuged at 2,500  g for 10 min
at 4°C. Formalin (0.3%) was then added to the supernatant, which contained
106.5 TCID50/ml virus. The virus was inactivated for 10 days at 4°C. Thus, three
inactivated vaccines were prepared.
Vaccination and challenge. A total of 1,200 juvenile red sea bream (body
weight, 8.3  3.8 g) were used as experimental fish. The fish were divided into
two sets of four groups. Each group consisted of 150 fish, which were reared in
an 800-liter aquarium supplied with running seawater at a controlled tempera-
ture of 28°C. In one set of fish, three groups were intraperitoneally injected with
0.1 ml of each vaccine preparation. The fourth group of fish received a PBS
injection as a control. Another set of four groups was immunized similarly. Three
weeks after vaccination, all the fish groups were challenged by intraperitoneal
infection with 0.1 ml of RSIV (U-6 strain) solution. The challenge test was
conducted by intraperitoneal injection with two doses of the RSIV U-6 strain.
One set (consisting of four groups) of fish was infected with RSIV at 104
TCID50/fish, and another set was infected with 103 TCID50/fish. The fish were
observed for 14 days for the clinical signs of disease, and dead fish were collected
every day. Statistical analysis was carried out using Fisher’s exact test. The
relative percentage survival (RPS) (1) was determined by the following formula:
RPS  [1 (percent mortality of immunized fish/percent mortality of control
fish)]  100.
Nucleotide sequence accession numbers. The nucleotide sequences of the
RSIV MCP region were deposited in the GenBank database under accession
numbers AB461856 (U-6) and AB461855 (KST-Y-1).
RESULTS
Phylogenetic analysis. The relationship between isolates and
previously reported iridoviruses (2, 9, 10, 15, 17, 21, 25, 27, 37,
39, 43) was determined by phylogenetic analysis (12, 36). There
were sequence variations in the MCP regions among the iso-
lates; however, all of the samples were similar to foreign iso-
lates, including OSGIV and RBIV (Fig. 1).
Genetic differences among isolates. PCR-RFLP to detect
genetic differences in the three isolates showed different pat-
terns of banding in two of the seven selective regions (Fig. 2).
In set 2, the banding pattern of U-6 showed differences from
the other two isolates. In the set 4, the banding pattern of U-1
showed differences from the two other isolates. Sets 1, 3, 5, 6,
and 7 did not show different banding patterns among the three
isolates.
Replication profile and virulence differences in vitro. Viral
replication was examined using real-time PCR with viral DNA
extracted from RSIV-infected CRF-1 cells and cell culture
FIG. 1. Phylogenetic analysis of MCP sequences. All sequences
were available in the GenBank and were analyzed using the Clustal W
program. RSIV strain ehime-1 was used as the outgroup. The signifi-
cance of branching order was assessed by bootstrap resampling of
1,000 replicates. The RSIV isolate sequenced in this study is repre-
sented in boldface. Genetic distance was proportional to horizontal
branch length and is indicated at the bottom of the figure.
FIG. 2. RFLP analysis of the three RSIV isolates. Lanes M indicate DNA length markers as follows: left, One Step Ladder 100 (Wako); right,
All Purpose Hi-Lo (Bionexus, Inc.). The lengths of specific marker bands (base pairs) are indicated at the right and left of the gel. Lanes A, B,
and C show RSIV isolates U-1, U-6, and KST-Y-1, respectively. Numbers above the lanes designate the sets of amplified regions and restriction
enzymes used as follows: 1, set 2 and HaeII; 2, set 4 and HaeII; 3, set 4 and HapII; 4, set 4 and NdeI; 5, set 6 and HapII.
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supernatant at the times indicated on Fig. 3. The replication
profile for KST-Y-1 differed from the profiles for U-1 and U-6.
The replication peak for KST-Y-1 appeared around 5 to 7 days
postinoculation, whereas the replication peak for U-6 and U-1
appeared at 3 days postinoculation.
An MTT assay was carried out to determine the virulence of
the three viral isolates in CRF-1 cells. Cell viability was deter-
mined by the relative rate of absorbance of infected cells com-
pared with that of mock-infected cells (Fig. 4). Significant
differences in cell viability were observed between cells in-
fected with the three RSIV isolates. The mean viability of cells
infected with U-6, KST-Y-1, and U-1 was 52%, 70%, and 4%,
respectively. Cells infected with U-1 experienced 33% viability
by day 4 postinoculation.
Electron microscopy. Virus particles of the three isolates
appeared at different inoculation times in the CRF-1 cell cul-
ture. The virus particles of U-1, U-6, and KST-Y-1 isolates
appeared at 2, 2, and 4 days after inoculation, respectively (Fig.
5). Virus particles were observed in small aggregations in the
cytoplasm of infected cells. Some results were observed in
replicates.
Virulence and virus distribution in infected fish. Mortality
profiles in fish infected with the three RSIV isolates are shown
in Fig. 6. Significant differences were detected between fish
infected with doses of 105, 104, and 103 TCID50 of the three
RSIV isolates, U-1, U-6, and KST-Y-1. Fish infected with U-6
showed a typical acute progression of the disease, and all
infected fish died within 7 to 9 days postinfection with 105 or
104 TCID50/fish. In contrast, 100%, 70%, and 30% of fish
infected with KST-Y-1 at 105, 104, and 103 TCID50/fish, re-
spectively, died within 8 to 11 days. Fish infected with U-1 at
105, 104, and 103 TCID50/fish showed 70%, 60%, and 20%
mortality, respectively, within 7 to 10 days. No morbidity or
mortality was observed in PBS-injected control fish.
Viral DNA was detected in all the selected tissues (liver,
kidney, spleen, heart, brain, and suborbital musculature) of fish
from 5 to 10 days after infection (Fig. 7). The spleen, liver, and
kidney tissues showed relatively strong signals. The DNA of
the U-6 strain had a different profile from the U-1 and KST-
Y-1 strains and was detected in all tissues within 5 to 8 days
postinjection. The DNA of the KST-Y-1 strain was first ob-
served in four tissues, spleen, kidney, liver, and heart, after
which it appeared in the brain and suborbital musculature.
Control fish were negative for viral DNA in all tissues through-
out the experimental period.
Enlarged cells were observed in the spleen, kidney, and liver
of three juvenile red sea bream 5 to 10 days after injection with
the three RSIV strains, and the spleen showed the highest
number of such cells.
FIG. 3. Viral genome copies in supernatant and cell pellets from
CRF-1 cell cultures inoculated with three RSIV isolates determined by
real-time qPCR. Points represent mean values of duplicated cell cul-
ture flasks inoculated with each isolate.
FIG. 4. Survival rate of CRF-1 cells infected with three RSIV iso-
lates measured by MTT assay. Infection dose was 50 l of 103 copies
of viral DNA of each isolate. Cell viability was calculated as the relative
rate of absorbance in virus-infected cells compared with that in mock-
infected cells and is represented as mean  standard deviation.
FIG. 5. Transmission electron microscopy images of RSIV parti-
cles observed in CRF-1 cells infected with the three RSIV isolates.
Images are of mock-infected cells (A) and cells infected with U-1 (B),
U-6 (C), or KST-Y-1 (D) virus. Virus particles were observed in small
aggregates in the cytoplasm after 48 h in U-1- and U-6-infected cells
and after 96 h in KST-Y-1-infected cells. Insets in each panel show
magnified images. Bar, 2.0 m.
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Mortality after challenge of immunized fish. Figure 8 shows
differences in the protective effects of vaccination in the im-
munized groups at two infection doses. Fish that were vacci-
nated with the vaccine for the U-6 strain showed the highest
survival rate, whereas fish vaccinated with the vaccine for the
KST-Y-1 strain showed the lowest survival rate. RPS values
obtained for the fish immunized with U-6, U-1, and KST-Y-1
strains were 69, 45, and 11%, respectively, at the higher infec-
tion dose.
DISCUSSION
Megalocytiviruses have been isolated from different fish spe-
cies and are considered pathogens of diseases that cause sig-
nificant economic losses in the fish aquaculture industry (2, 6,
7, 25, 31, 37, 38, 39). Most studies of these viruses have been on
the genetic relationships between emerging strains; however,
studies linking these genetic findings to viral phenotypic char-
acteristics are almost absent. One objective of this study was to
clarify the phenotypes, especially virulence characteristics, of
different emerging viral isolates.
We have demonstrated that RSIVs isolated from western
Japan differ genetically and pathogenically in vivo and in vitro.
Nucleotide sequence and phylogenetic analysis revealed that
most of the isolates were similar to OSGIV, RBIV, and grou-
per sleepy disease virus, demonstrating that RSIV isolates have
different phenotypes. The three isolates showed different band
patterns by RFLP analysis.
FIG. 6. Cumulative mortality of red sea bream infected intraperi-
toneally with three doses of the RSIV isolates U-1 (A), U-6 (B), and
KST-Y-1 (C). Infection doses are as follows: 105 (f), 104 (F), and 103
(Œ) TCID50/fish, and PBS as a control (). RSIV was not detected in
mock-infected control fish.
FIG. 7. Distribution of the RSIV ATPase gene in the tissue of red sea bream infected with the three RSIV isolates at a 60% lethal dose: for
U-1, 104 TCID50/fish; for U-6, 10
3 TCID50/fish; and for KST-Y-1, 10
4 TCID50/fish. Virus was detected by PCR. Eye* indicates eye musculature
tissue.
FIG. 8. Survival rate of vaccinated fish after challenge with at a
high dose and low dose of the U-6 strain. Infection doses were 103
TCID50/fish (A) and 10
4 TCID50/fish (B).
VOL. 75, 2009 DIVERSIFICATION IN AN IRIDOVIRUS 3539
Phenotypical differences were also observed among the
three isolates in vitro. U-6 and U-1 showed higher replication
rates and virulence than KST-Y-1 in CRF-1 cells that origi-
nated from the fin tissue of red sea bream. Virus particles
appeared in U-6- and U-1-infected cells earlier than in KST-
Y-1-infected cells. Higher viral replication and virulence were
found in the red sea bream isolates U-1 and U-6, whereas the
KST-Y-1 yellow tail isolates showed low activity.
The isolates also showed different virulence profiles in an
experimental infection in juvenile red sea bream. U-6 was
highly virulent, showing acute progression and death, whereas
KST-Y-1 and U-1 demonstrated subacute profiles. To assess
viral tropism, virus distribution in fish tissues after RSIV in-
fection was examined, and differences in the proliferation and
distribution of virus strains were observed. U-6 had broad
distribution in the heart, brain, and eye musculature. Numer-
ous accumulations of KST-Y-1 virus particles were found in
the spleen, liver, and kidney, and distribution in the heart,
brain, and eye musculature occurred in the late stages of in-
fection. U-1 showed numerous accumulations of virus in the
spleen and liver; however, this strain also had broad distribu-
tion with slight detection in other tissues. These results show
that the variation in distribution for these different emerging
viral isolates is strongly related to their virulence profiles.
In Megalocytivirus infection, diseased fish show numerous
accumulations of virus particles in the spleen and kidney (6,
39). The spleen has been reported to be the most susceptible
organ in iridoviral disease (28). The three isolates used in the
infection experiment showed the accumulation of virus genes
in the spleen and kidney; however, virus genes were detected in
the liver, heart, brain, and eye musculature at the time many
fish were dying. These results suggest that systemic prolifera-
tion of the virus readily causes the death of fish. A similar
disease profile has been reported for the frog virus 3, a virus of
the Ranavirus genus. A susceptible amphibian species infected
with the virus showed preferential distribution of the virus in
the kidney although the animal persisted for a long time (13);
however, systemic spreading of the virus to most organs in the
visceral cavity caused acute disease progression and death (35).
The virulence mechanisms of megalocytiviruses have been
studied in vitro; however, very few attempts have been made to
characterize strain-specific virulence factors as well as to elu-
cidate host-related and ecological factors in vivo.
The three isolates used in this study have the same MCP
nucleotide sequence; however, different levels of protection
occurred in the immunization and challenge experiments. Im-
munization with U-6 was significantly protective against U-6-
infection in juvenile red sea bream, showing a more than 35%
higher protection rate than KST-Y-1 immunization and more
than 10% higher protection than U-1 immunization. Previous
studies suggest that the MCP gene of RSIV is an effective
component in a genetic vaccine test (4, 26) and a formalin-
inactivated virus vaccine test (3). The formalin-inactivated vi-
rus vaccine used in this study represents the MCP region plus
other gene products of the virus. These results suggest that
careful selection of viral strains is necessary when inactivated
vaccine is being developed.
It has been suggested that the worldwide distributed mega-
locytiviruses have a common origin (38, 39). Furthermore, it
has been strongly suggested that iridoviruses and recently dis-
covered viruses lately differentiated from the same origin (15).
The present study has revealed that iridoviruses include vari-
ants although they are located in the same phylogenetic posi-
tion according to the MCP gene sequence. Additionally, the
result of this study revealed that viruses with different pheno-
types infect the same species of host. Similar cases were re-
ported also for largemouth bass virus (16). Our results support
a hypothesis that there are many phenotypes of viruses of the
Iridoviridae family in the environment and that these viruses
infect different host species, cause different symptoms, and
produce different mortality rates. In order to elucidate this
presumption, further study is necessary. In Iridoviridae, there is
a lack of information about genome organization or factors
affecting host range. The aim of our work is to find effective
ways of controlling the iridovirus infection, and we hope the
findings in this study will be useful.
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